Concepedia
Statistics
Publications
4
Citations
293
H-Index
Active since
2001
Affiliations
Rosetta Stone (United States)(Current)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Marcia Gordon is an author at Rosetta Stone (United States) specializing in molecular biology, life sciences, and oncology.
Publications per year
2001–2013
Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 Disruptions
Steven R. Bartz, Zhan Zhang, Julja Burchard et al. · Molecular and Cellular Biology · 2006 · 179 citations
Life Sciences, Molecular Biology, Oncology +13
Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1
Yu Shen, Ralf M. Luche, Bo Wei et al. · Proceedings of the National Academy of Sciences · 2001 · 91 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +16
An Inducible, Isogenic Cancer Cell Line System for Targeting the State of Mismatch Repair Deficiency
Julie M. Bailis, Marcia Gordon, Jesse L. Gurgel et al. · PLoS ONE · 2013 · 13 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ
Paul Warrener, Sammy Kim, Sybil M. Genther Williams et al. · APOPTOSIS · 2012 · 10 citations
Life Sciences, Cancer Biology, Oncology +17
1–4 of 4